Exosomes from pediatric dilated cardiomyopathy patients modulate a pathological response in cardiomyocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 312, Issue 4, 2017, Pages H818-H826

  Jiang, Xuan ^a   Sucharov, Juliana ^a,b   Stauffer, Brian L ^a,c   Miyamoto, Shelley D ^d   Sucharov, Carmen C ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^d University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

Cellular hypertrophy; Exosomes; Fetal gene program; Pediatric dilated cardiomyopathy

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; ISOPRENALINE; LOSARTAN; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL;

ADRENERGIC SYSTEM; ADULT; ANIMAL CELL; ARTICLE; CARDIAC MUSCLE CELL; CELL SIZE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EXOSOME; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INDUCED PLURIPOTENT STEM CELL; INDUCED PLURIPOTENT STEM CELL DERIVED CARDIOMYOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION; ANIMAL; BLOOD; CELL CULTURE; CHILD; CYTOLOGY; DRUG EFFECTS; HEART VENTRICLE; INFANT; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RAT; SERUM; SPRAGUE DAWLEY RAT; STEM CELL TRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; CARDIOMYOPATHY, DILATED; CELL SIZE; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; EXOSOMES; FEMALE; GENE EXPRESSION; HEART VENTRICLES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFANT; MALE; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; SERUM; STEM CELL TRANSPLANTATION; SYMPATHETIC NERVOUS SYSTEM;

EID: 85017312616     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00673.2016     Document Type: Article

References (32)

1. Ailawadi S, Wang X, Gu H, Fan GC. Pathologic function and therapeutic potential of exosomes in cardiovascular disease. Biochim Biophys Acta 1852: 1-11, 2015. doi:10.1016/j.bbadis.2014.10.008.
2. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, Ponimaskin E, Schmiedl A, Yin X, Mayr M, Halder R, Fischer A, Engelhardt S, Wei Y, Schober A, Fiedler J, Thum T. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124: 2136-2146, 2014. doi:10.1172/JCI70577.
3. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, Anderson FL, Murray J, Mestroni L, Karwande SV, Fowler M, Ginburg M. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 89: 803-815, 1992. doi:10.1172/JCI115659.
4. Chatfield KC, Sparagna GC, Sucharov CC, Miyamoto SD, Grudis JE, Sobus RD, Hijmans J, Stauffer BL. Dysregulation of cardiolipin biosynthesis in pediatric heart failure. J Mol Cell Cardiol 74: 251-259, 2014. doi:10.1016/j.yjmcc.2014.06.002.
5. Dzau VJ. Clinical implications for therapy: possible cardioprotective effects of ACE inhibition. Br J Clin Pharmacol 28, Suppl 2: 183S-187S, 1989. doi:10.1111/j.1365-2125.1989.tb03594.x.
6. Franzen CA, Simms PE, Van Huis AF, Foreman KE, Kuo PC, Gupta GN. Characterization of uptake and internalization of exosomes by bladder cancer cells. BioMed Res Int 2014: 619829, 2014. doi:10.1155/2014/ 619829.
7. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation 109: 1580-1589, 2004. doi:10.1161/01. CIR.0000120390.68287.BB.
8. Heusermann W, Hean J, Trojer D, Steib E, von Bueren S, Graff-Meyer A, Genoud C, Martin K, Pizzato N, Voshol J, Morrissey DV, Andaloussi SE, Wood MJ, Meisner-Kober NC. Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER. J Cell Biol 213: 173-184, 2016. doi:10.1083/ jcb.201506084.
9. Kantor PF, Abraham JR, Dipchand AI, Benson LN, Redington AN. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy. J Am Coll Cardiol 55: 1377-1384, 2010. doi:10.1016/j.jacc.2009.11.059.
10. Khalyfa A, Gozal D. Exosomal miRNAs as potential biomarkers of cardiovascular risk in children. J Transl Med 12: 162, 2014. doi:10.1186/ 1479-5876-12-162.
11. Khan M, Nickoloff E, Abramova T, Johnson J, Verma SK, Krishnamurthy P, Mackie AR, Vaughan E, Garikipati VN, Benedict C, Ramirez V, Lambers E, Ito A, Gao E, Misener S, Luongo T, Elrod J, Qin G, Houser SR, Koch WJ, Kishore R. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res 117: 52-64, 2015. doi:10.1161/CIRCRESAHA.117.305990.
12. Krum H, Abraham WT. Heart failure. Lancet 373: 941-955, 2009. doi:10.1016/S0140-6736(09)60236-1.
13. Lionetti V, Bianchi G, Recchia FA, Ventura C. Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. Heart Fail Rev 15: 531-542, 2010. doi:10.1007/s10741-010-9165-7.
14. Liu Y, Cao X. Organotropic metastasis: role of tumor exosomes. Cell Res 26: 149-150, 2016. doi:10.1038/cr.2015.153.
15. Medina E, Sucharov CC, Nelson P, Miyamoto SD, Stauffer BL. Molecular changes in children with heart failure undergoing left ventricular assist device therapy. J Pediatr. In press. doi:10.1016/j.jpeds.2016. 11.011.
16. Miyamoto SD, Stauffer BL, Nakano S, Sobus R, Nunley K, Nelson P, Sucharov CC. Beta-adrenergic adaptation in paediatric idiopathic dilated cardiomyopathy. Eur Heart J 35: 33-41, 2014. doi:10.1093/eurheartj/ ehs229.
17. Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 3: 3, 2014. doi:10.3402/jev. v3.24641.
18. Nakano SJ, Miyamoto SD, Movsesian M, Nelson P, Stauffer BL, Sucharov CC. Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy. Circ Heart Fail 8: 57-63, 2015. doi:10.1161/ CIRCHEARTFAILURE.114.001218.
19. Ono K, Kuwabara Y, Han J. MicroRNAs and cardiovascular diseases. FEBS J 278: 1619-1633, 2011. doi:10.1111/j.1742-4658.2011.08090.x.
20. Pironti G, Strachan RT, Abraham D, Mon-Wei Yu S, Chen M, Chen W, Hanada K, Mao L, Watson LJ, Rockman HA. Circulating exosomes induced by cardiac pressure overload contain functional angiotensin II type 1 receptors. Circulation 131: 2120-2130, 2015. doi:10.1161/ CIRCULATIONAHA.115.015687.
21. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200: 373-383, 2013. doi:10.1083/jcb. 201211138.
22. Rekker K, Saare M, Roost AM, Kubo AL, Zarovni N, Chiesi A, Salumets A, Peters M. Comparison of serum exosome isolation methods for microRNA profiling. Clin Biochem 47: 135-138, 2014. doi:10.1016/ j.clinbiochem.2013.10.020.
23. Savina A, Vidal M, Colombo MI. The exosome pathway in K562 cells is regulated by Rab11. J Cell Sci 115: 2505-2515, 2002.
24. Spiltoir JI, Stratton MS, Cavasin MA, Demos-Davies K, Reid BG, Qi J, Bradner JE, McKinsey TA. BET acetyl-lysine binding proteins control pathological cardiac hypertrophy. J Mol Cell Cardiol 63: 175-179, 2013. doi:10.1016/j.yjmcc.2013.07.017.
25. Stauffer BL, Russell G, Nunley K, Miyamoto SD, Sucharov CC. miRNA expression in pediatric failing human heart. J Mol Cell Cardiol 57: 43-46, 2013. doi:10.1016/j.yjmcc.2013.01.005.
26. Sucharov CC, Dockstader K, McKinsey TA. YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5. Mol Biol Cell 19: 4141-4153, 2008. doi:10.1091/mbc.E07-12-1217.
27. 1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am J Physiol Heart Circ Physiol 291: H1299-H1308, 2006. doi:10.1152/ajpheart.00017.2006.
28. Thrush PT, Hoffman TM. Pediatric heart transplantation-indications and outcomes in the current era. J Thorac Dis 6: 1080-1096, 2014.10.3978/ j.issn.2072-1439.2014.06.16.
29. Vicencio JM, Yellon DM, Sivaraman V, Das D, Boi-Doku C, Arjun S, Zheng Y, Riquelme JA, Kearney J, Sharma V, Multhoff G, Hall AR, Davidson SM. Plasma exosomes protect the myocardium from ischemiareperfusion injury. J Am Coll Cardiol 65: 1525-1536, 2015. doi:10.1016/ j.jacc.2015.02.026.
30. Wilson KD, Sun N, Huang M, Zhang WY, Lee AS, Li Z, Wang SX, Wu JC. Effects of ionizing radiation on self-renewal and pluripotency of human embryonic stem cells. Cancer Res 70: 5539-5548, 2010. doi:10. 1158/0008-5472.CAN-09-4238.
31. Woulfe KC, Siomos AK, Nguyen H, SooHoo M, Galambos C, Stauffer BL, Sucharov C, Miyamoto S, SooHoo M, Galambo C, Stauffer BL, Sucharov C, Miyamoto S. Fibrosis and fibrotic gene expression in pediatric and adult patients with idiopathic dilated cardiomyopathy. J Card Fail. In press. doi:10.1016/j.cardfail.2016.11.006.
32. Yoshioka J, Prince RN, Huang H, Perkins SB, Cruz FU, MacGillivray C, Lauffenburger DA, Lee RT. Cardiomyocyte hypertrophy and degradation of connexin43 through spatially restricted autocrine/paracrine heparin-binding EGF. Proc Natl Acad Sci USA 102: 10622-10627, 2005. doi:10.1073/pnas.0501198102.